Market Cap 53.87B
Revenue (ttm) 222.58B
Net Income (ttm) 1.56B
EPS (ttm) N/A
PE Ratio 21.77
Forward PE 18.86
Profit Margin 0.70%
Debt to Equity Ratio -3.34
Volume 2,094,400
Avg Vol 2,286,310
Day's Range N/A - N/A
Shares Out 234.21M
Stochastic %K 99%
Beta 0.49
Analysts Strong Sell
Price Target $253.50

Company Profile

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and...

Industry: Medical Distribution
Sector: Healthcare
Phone: 614 757 5000
Address:
7000 Cardinal Place, Dublin, United States
GenevaNolden853
GenevaNolden853 Aug. 3 at 2:43 PM
$CAH $KEYS $LNG $COHR $TAK Cardinal Health benefits from healthcare distribution, Keysight leads electronic testing equipment, Cheniere Energy benefits from growing LNG exports, Coherent rides AI photonics demand, and Takeda continues expanding its global pharmaceutical portfolio.
0 · Reply
bhunts4
bhunts4 Jul. 29 at 9:47 PM
$CAH this is the golden economy wow
0 · Reply
Reanimated666
Reanimated666 Jul. 24 at 12:22 PM
$CAH False breakout and trending down
0 · Reply
JackDarwin
JackDarwin Jul. 24 at 10:34 AM
$CAH Tweezer Bottom with Good Volume.
0 · Reply
DrMunch
DrMunch Jul. 22 at 11:01 PM
$CAH Same market cap as $MDLN but has 8x higher revenue. How does this add up?
3 · Reply
prismmarketview
prismmarketview Jul. 21 at 5:35 PM
$CAH Cardinal Health is acquiring AdaptHealth’s Diabetes Health business + Strive Medical for about $360M in cash. Both roll into at‑Home Solutions, boosting recurring revenue in diabetes and urology. #CAH #AHCO #StriveMedical #homecare https://prismmarketview.com/cardinal-health-buys-diabetes-and-home-care-assets-in-a-360-million-push-into-at-home-chronic-care/
0 · Reply
AXLFI_HQ
AXLFI_HQ Jul. 21 at 12:36 AM
$CAH Healthcare companies and diversified corporations are executing strategic acquisitions and portfolio optimization to consolidate fragmented markets and improve operational efficiency, with tuck-in acquisitions and divestitures creating value through market consolidation. Learn more: https://axlfi.com/themes/379
0 · Reply
MarketLensX
MarketLensX Jul. 20 at 9:34 PM
$CAH — Cardinal Health to buy AdaptHealth's diabetes business, Strive Medical for about $360 mln cash (225.75 -2.77) Cardinal Health entered definitive agreements to acquire AdaptHealth's (AHCO) Diabetes Health business and privately held Strive Medical, expanding its at-Home Solutions platform in diabetes and urology. The two tuck-in deals total about $360 mln in cash, subject to working capital adjustments, and are expected to be accretive to non-GAAP EPS within 12 months of closing. AdaptHealth's diabetes unit serves more than 225,000 people annually through a centralized mail-order direct-to-patient model; Strive Medical serves more than 20,000 people annually across urology, wound care, ostomy and incontinence. Both transactions remain subject to customary closing conditions, including required regulatory approvals.
0 · Reply
JodieChristy
JodieChristy Jul. 20 at 9:16 PM
Strategic expansion unlocked! $CAH strengthens its healthcare platform with new acquisitions Cardinal Health ($CAH) trades at $225.75 (-1.21%) as buyers continue absorbing sector pressure near key support zones. CAH announced ~$360M cash acquisitions of AdaptHealth’s Diabetes unit and Strive Medical, adding 245,000+ annual patients and expected EPS accretion within 12 months. The chart is building a story. Watch key levels and confirmation.
0 · Reply
bhunts4
bhunts4 Jul. 16 at 1:58 PM
$CAH buying the dip. Thank you
0 · Reply
Latest News on CAH
Cardinal Health price target raised to $265 from $245 at Citi

2026-07-24T10:40:12.000Z - 10 days ago

Cardinal Health price target raised to $265 from $245 at Citi


Cardinal Health price target raised to $274 from $260 at UBS

2026-07-20T13:25:06.000Z - 14 days ago

Cardinal Health price target raised to $274 from $260 at UBS


Cardinal Health price target raised to $260 from $240 at BofA

2026-07-02T10:40:44.000Z - 4 weeks ago

Cardinal Health price target raised to $260 from $240 at BofA


The Healthcare M&A Wave

Jun 17, 2026, 12:30 PM EDT - 6 weeks ago

The Healthcare M&A Wave

ABT ALNY AMGN AMRX ANTX AZN BDX


Cardinal Health Board of Directors Approves Quarterly Dividend

May 5, 2026, 4:40 PM EDT - 3 months ago

Cardinal Health Board of Directors Approves Quarterly Dividend


Cardinal Health price target lowered to $248 from $257 at Baird

2026-05-01T14:46:28.000Z - 3 months ago

Cardinal Health price target lowered to $248 from $257 at Baird


Cardinal Health price target lowered to $245 from $249 at Citi

2026-05-01T10:41:36.000Z - 3 months ago

Cardinal Health price target lowered to $245 from $249 at Citi


Cardinal Health price target lowered to $240 from $260 at BofA

2026-04-30T17:34:52.000Z - 3 months ago

Cardinal Health price target lowered to $240 from $260 at BofA


Cardinal Health Earnings Call Transcript: Q3 2026

Apr 30, 2026, 8:30 AM EDT - 3 months ago

Cardinal Health Earnings Call Transcript: Q3 2026


Cardinal Health Earnings release: Q3 2026

Apr 30, 2026, 8:30 AM EDT - 3 months ago

Cardinal Health Earnings release: Q3 2026


Cardinal Health Slides: Q3 2026

Apr 30, 2026, 8:30 AM EDT - 3 months ago

Cardinal Health Slides: Q3 2026


Cardinal Health Quarterly report: Q3 2026

Apr 30, 2026, 8:30 AM EDT - 3 months ago

Cardinal Health Quarterly report: Q3 2026


Cardinal Health Lifts Outlook Again as Revenue Rises

Apr 30, 2026, 7:41 AM EDT - 3 months ago

Cardinal Health Lifts Outlook Again as Revenue Rises


Cardinal Health reports Q3 EPS $3.17, consensus $2.79

2026-04-30T10:58:24.000Z - 3 months ago

Cardinal Health reports Q3 EPS $3.17, consensus $2.79


Cardinal Health initiated with an Outperform at William Blair

2026-04-28T10:12:49.000Z - 3 months ago

Cardinal Health initiated with an Outperform at William Blair


Cardinal Health Earnings Call Transcript: Q2 2026

Feb 5, 2026, 8:30 AM EST - 6 months ago

Cardinal Health Earnings Call Transcript: Q2 2026


Cardinal Health Quarterly report: Q2 2026

Feb 5, 2026, 8:30 AM EST - 6 months ago

Cardinal Health Quarterly report: Q2 2026


Cardinal Health Earnings release: Q2 2026

Feb 5, 2026, 8:30 AM EST - 6 months ago

Cardinal Health Earnings release: Q2 2026


Cardinal Health Slides: Q2 2026

Feb 5, 2026, 8:30 AM EST - 6 months ago

Cardinal Health Slides: Q2 2026


Cardinal Health Lifts Outlook After Posting Higher Profit

Feb 5, 2026, 7:35 AM EST - 6 months ago

Cardinal Health Lifts Outlook After Posting Higher Profit


Cardinal Health raises 2026 profit forecast

Jan 13, 2026, 6:58 AM EST - 7 months ago

Cardinal Health raises 2026 profit forecast


Cardinal Health completes acquisition of Solaris Health

Nov 3, 2025, 8:30 AM EST - 9 months ago

Cardinal Health completes acquisition of Solaris Health


Cardinal Health Earnings Call Transcript: Q1 2026

Oct 30, 2025, 8:30 AM EDT - 9 months ago

Cardinal Health Earnings Call Transcript: Q1 2026


Cardinal Health Earnings release: Q1 2026

Oct 30, 2025, 8:30 AM EDT - 9 months ago

Cardinal Health Earnings release: Q1 2026


Cardinal Health Quarterly report: Q1 2026

Oct 30, 2025, 8:30 AM EDT - 9 months ago

Cardinal Health Quarterly report: Q1 2026


Cardinal Health Slides: Q1 2026

Oct 30, 2025, 8:30 AM EDT - 9 months ago

Cardinal Health Slides: Q1 2026


Cardinal Health Proxy statement: Proxy Filing

Sep 16, 2025, 8:00 AM EDT - 11 months ago

Cardinal Health Proxy statement: Proxy Filing


Cardinal Health Proxy statement: Proxy Filing

Sep 16, 2025, 8:00 AM EDT - 11 months ago

Cardinal Health Proxy statement: Proxy Filing


Cardinal Health to Extend Reach by Acquiring Solaris Health

Aug 12, 2025, 2:28 PM EDT - 1 year ago

Cardinal Health to Extend Reach by Acquiring Solaris Health


Cardinal Health Earnings Call Transcript: Q4 2025

Aug 12, 2025, 8:30 AM EDT - 1 year ago

Cardinal Health Earnings Call Transcript: Q4 2025


Cardinal Health Annual report: Q4 2025

Aug 12, 2025, 8:30 AM EDT - 1 year ago

Cardinal Health Annual report: Q4 2025


Cardinal Health Earnings release: Q4 2025

Aug 12, 2025, 8:30 AM EDT - 1 year ago

Cardinal Health Earnings release: Q4 2025


Cardinal Health Slides: Q4 2025

Aug 12, 2025, 8:30 AM EDT - 1 year ago

Cardinal Health Slides: Q4 2025


Cardinal Health to buy Solaris Health for $1.9 billion

Aug 12, 2025, 6:54 AM EDT - 1 year ago

Cardinal Health to buy Solaris Health for $1.9 billion


CAH CFO on Pharmaceutical Distributor's Outlook

Jun 12, 2025, 7:30 PM EDT - 1 year ago

CAH CFO on Pharmaceutical Distributor's Outlook


Cardinal Health Transcript: Investor Day 2025

Jun 12, 2025, 9:00 AM EDT - 1 year ago

Cardinal Health Transcript: Investor Day 2025


Cardinal Health Press release: FY 2025

Jun 12, 2025, 9:00 AM EDT - 1 year ago

Cardinal Health Press release: FY 2025


Cardinal Health Slides: FY 2025

Jun 12, 2025, 9:00 AM EDT - 1 year ago

Cardinal Health Slides: FY 2025


Cardinal Health raises annual profit target

Jun 12, 2025, 7:31 AM EDT - 1 year ago

Cardinal Health raises annual profit target


Cramer's Stop Trading: Cardinal Health

Jun 10, 2025, 10:24 AM EDT - 1 year ago

Cramer's Stop Trading: Cardinal Health


GenevaNolden853
GenevaNolden853 Aug. 3 at 2:43 PM
$CAH $KEYS $LNG $COHR $TAK Cardinal Health benefits from healthcare distribution, Keysight leads electronic testing equipment, Cheniere Energy benefits from growing LNG exports, Coherent rides AI photonics demand, and Takeda continues expanding its global pharmaceutical portfolio.
0 · Reply
bhunts4
bhunts4 Jul. 29 at 9:47 PM
$CAH this is the golden economy wow
0 · Reply
Reanimated666
Reanimated666 Jul. 24 at 12:22 PM
$CAH False breakout and trending down
0 · Reply
JackDarwin
JackDarwin Jul. 24 at 10:34 AM
$CAH Tweezer Bottom with Good Volume.
0 · Reply
DrMunch
DrMunch Jul. 22 at 11:01 PM
$CAH Same market cap as $MDLN but has 8x higher revenue. How does this add up?
3 · Reply
prismmarketview
prismmarketview Jul. 21 at 5:35 PM
$CAH Cardinal Health is acquiring AdaptHealth’s Diabetes Health business + Strive Medical for about $360M in cash. Both roll into at‑Home Solutions, boosting recurring revenue in diabetes and urology. #CAH #AHCO #StriveMedical #homecare https://prismmarketview.com/cardinal-health-buys-diabetes-and-home-care-assets-in-a-360-million-push-into-at-home-chronic-care/
0 · Reply
AXLFI_HQ
AXLFI_HQ Jul. 21 at 12:36 AM
$CAH Healthcare companies and diversified corporations are executing strategic acquisitions and portfolio optimization to consolidate fragmented markets and improve operational efficiency, with tuck-in acquisitions and divestitures creating value through market consolidation. Learn more: https://axlfi.com/themes/379
0 · Reply
MarketLensX
MarketLensX Jul. 20 at 9:34 PM
$CAH — Cardinal Health to buy AdaptHealth's diabetes business, Strive Medical for about $360 mln cash (225.75 -2.77) Cardinal Health entered definitive agreements to acquire AdaptHealth's (AHCO) Diabetes Health business and privately held Strive Medical, expanding its at-Home Solutions platform in diabetes and urology. The two tuck-in deals total about $360 mln in cash, subject to working capital adjustments, and are expected to be accretive to non-GAAP EPS within 12 months of closing. AdaptHealth's diabetes unit serves more than 225,000 people annually through a centralized mail-order direct-to-patient model; Strive Medical serves more than 20,000 people annually across urology, wound care, ostomy and incontinence. Both transactions remain subject to customary closing conditions, including required regulatory approvals.
0 · Reply
JodieChristy
JodieChristy Jul. 20 at 9:16 PM
Strategic expansion unlocked! $CAH strengthens its healthcare platform with new acquisitions Cardinal Health ($CAH) trades at $225.75 (-1.21%) as buyers continue absorbing sector pressure near key support zones. CAH announced ~$360M cash acquisitions of AdaptHealth’s Diabetes unit and Strive Medical, adding 245,000+ annual patients and expected EPS accretion within 12 months. The chart is building a story. Watch key levels and confirmation.
0 · Reply
bhunts4
bhunts4 Jul. 16 at 1:58 PM
$CAH buying the dip. Thank you
0 · Reply
ArkyCapital
ArkyCapital Jul. 9 at 5:22 PM
$CAH guess we're rotating again? Will add if we dip back under 200. Otherwise, solid hold.
0 · Reply
bhunts4
bhunts4 Jul. 6 at 2:24 PM
$CAH buy the dip
0 · Reply
WAJeff
WAJeff Jun. 26 at 6:29 PM
$CAH $240.39 ath
0 · Reply
PhoenixRisingMD
PhoenixRisingMD Jun. 26 at 2:27 PM
$CAH beautiful. Great long term hold
0 · Reply
Reanimated666
Reanimated666 Jun. 26 at 2:26 PM
$CAH Good clean breakout going on
0 · Reply
BillionerOfKing
BillionerOfKing Jun. 26 at 12:56 AM
$CAH Current Stock Price: $234.77 Contracts to trade: $235.0 CAH Jun 26 2026 Call Entry: $1.00 Exit: $1.31 ROI: 31% Hold ~28 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
ArkyCapital
ArkyCapital Jun. 25 at 11:14 PM
$CAH cut my position in half. Holding with an average of ~202, planning to stick around. Happy to add if it dips back down.
0 · Reply
abubnic
abubnic Jun. 25 at 2:38 PM
$CAH Slow but steady-moving stock. Been in it since 2022 and am up 370%. Pays a nice dividend of $0.518, too. Reliable. Currently at a 52-week high. The company made a structural transition from a low-margin drug distributor into a high-margin specialty medicine platform. $CAH is tracking to exceed $50 billion in specialty revenues for fiscal year 2026.
0 · Reply
SuperGreenToday
SuperGreenToday Jun. 24 at 6:55 AM
$CAH Share Price: $228.91 Contract Selected: Jul 17, 2026 $230 Calls Buy Zone: $3.82 – $4.73 Target Zone: $6.46 – $7.90 Potential Upside: 60% ROI Time to Expiration: 23 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Reanimated666
Reanimated666 Jun. 16 at 4:02 PM
$CAH reversal complete long
0 · Reply
DanaBlack
DanaBlack Jun. 11 at 6:43 PM
$CAH can you fucking move more 2-3% at a time??? Please and thank you
0 · Reply
Kosmos709
Kosmos709 Jun. 9 at 4:33 PM
This man shares my style of investing. He chooses good names -- he also can smell the incoming volitility and choose lower beta names to ride out the wave. I used to make such posts but most people on st are only interested in instant 100% gains a day or they believe in the bum furu with thousands of lemmings following them. Follow @WuTangClam -- he is a real one. he did leave off some other names like $CVS $CAH $UNH that the algos positioned themselves for awhile to go hide out -- especially since the pullbacks. Good luck to anyone that bothers to use their brain today.
1 · Reply